fls.txt
All statements contained herein that are not statements of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements, and may contain the word believe, anticipate, expect, project, intend, will continue, will likely result, should or words or phrases of similar meaning.


item1.txt
For a full discussion of these risk factors, please refer to Item 1A.


item2.txt
Item 2.
Excluding the unfavorable effects of foreign currency exchange (FX) of $2,010, second quarter revenue was $94,640, up 18.3%.
For the six months ended June 30, 2019, excluding the unfavorable effects of FX of $5,150, revenue was $191,676, up 22.4%.
Revenue excluding foreign currency exchange impacts is a non-GAAP measurement.
Improved product mix helped to overcome an ongoing supplier issue.
Sales to U.S. customers were 58% of total sales for the quarter compared with 52% for the same period last year, with the balance of sales to customers primarily in Europe, Canada and Asia.
Sales to U.S. customers were 56% of total sales for 2019 compared with 52% for the same period last year, with the balance of sales to customers primarily in Europe, Canada and Asia.
Sales volume increased by 22.4% for the six months ended June 30, 2019, offset by a 3.3% unfavorable currency impact.
Revenue excluding foreign currency exchange impacts, EBITDA and Adjusted EBITDA are provided for information purposes only and are not measures of financial performance under GAAP.
The Company believes that revenue excluding foreign currency exchange impacts is a useful measure in analyzing organic sales results.
During the second quarter of 2019, the increase in cash provided by operating activities is primarily due to a decrease in working capital needs primarily for inventories despite increased revenues along with higher levels of orders, particularly in the second quarter of 2019.
During the second quarter of 2019, the Company made payments on the revolver that offset all but $695 of the 2019 borrowings.
The Credit Agreement also includes other covenants and restrictions, including limits on the amount of additional indebtedness, and restrictions on the ability to merge, consolidate or sell all or substantially all our assets.
We were in compliance with all covenants at June 30, 2019.
As of June 30, 2019, the amount available to borrow under the Credit Agreement was approximately $51,305.
There were no borrowings for the China Facility balance during the quarter ended June 30, 2019.


item3.txt
Net foreign currency transaction gains and losses included in other income, net amounted to a gain of $19 and $294 for the second quarter of 2019 and 2018, respectively.
For the six months ended June 30, 2019 and 2018, net foreign currency transaction gains and losses included in other income, net were a loss of $58 and a gain of $156, respectively.
A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency net assets would have had an impact of approximately $7,100 on our foreign net assets as of June 30, 2018.
exposure to interest rate movements.
During October 2013, the Company entered into two interest rate swaps with a combined notional of $25,000 that amortized quarterly to a notional of $6,673 at the September 2018 maturity.
Neither of these interest rate swaps is currently active, one was liquidated as part of the 2016 debt refinancing and the other matured in September 2018.


item4.txt
Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.


part2.txt
Item 1A.
Item 2.
Item 5.


